Sort
21,281 grants matching “influenza”
Control of influenza virus induced type I interferon signaling during pregnancy
$745,177Nicholas S Heaton · Duke University · R01 · FY2025 · AI
Exploring the role of T cells in protection from respiratory virus transmission
$744,977Jacob E Kohlmeier · Emory University · R01 · FY2025 · AI
Heterosubtypic immunity to influenza virus mediated by MHC-E-restricted memory NK cells
$744,953Stephanie Jost · Duke University · R01 · FY2025 · AI
Identifying Influenza Virus Infection Severity and Outcome Signatures Through Artificial Intelligence-driven Analyses
$744,912Christopher L. Dupont · J. Craig Venter Institute, Inc. · R01 · FY2025 · AI
Combined adjuvant approaches for enhancement of SARS-CoV-2 vaccine efficacy
$744,600Pamela Tinmoi Wong · University Of Michigan At Ann Arbor · R01 · FY2022 · AI
Forecasting influenza evolution on a heterogeneous immune landscape
$744,369Trevor Bc Bedford · Fred Hutchinson Cancer Center · R01 · FY2025 · AI
Forecasting influenza evolution on a heterogeneous immune landscape
$744,369Trevor Bc Bedford · Fred Hutchinson Cancer Center · R01 · FY2023 · AI
Human Immunology Center at the University of Rochester
$744,313Tim Mosmann · University Of Rochester · R24 · FY2009 · AI
The Role of Nasal Mucosal Immunity and Microbiome on the Frequent Exacerbation Phenotype of COPD
$744,150Michael Bradley Drummond · Univ Of North Carolina Chapel Hill · R01 · FY2021 · HL
ATD: DEEP SEQUENCING OF MICROBIAL POPULATIONS: DISENTANGLING DIVERSITY, DYNAMICS, AND ERRORS
$744,131Daniel S Fisher · Stanford University · · FY2011 · MPS
Meditation and Exercise for Preventing Acute Respiratory Infection (MEPARI-2)
$744,046Bruce P Barrett · University Of Wisconsin-Madison · R01 · FY2016 · AT
Tfh dysfunction in HIV and Aging
$743,891Savita Pahwa · University Of Miami School Of Medicine · R01 · FY2023 · AG
Non-Pharmaceutical Interventions for Pandemix Influenza
$743,754Scott F. Wetterhall · Research Triangle Institute · U01 · FY2007 · CI
Design and Analysis of Vaccine Trials for Emerging Infectious Disease Threats
$743,713Natalie Exner Dean · University Of Florida · R01 · FY2018 · AI
Deep sequencing of pathogens to precisely define transmission networks using rare variants
$743,465William Hanage · Harvard School Of Public Health · R01 · FY2020 · AI
Tissue resident memory T cells and chronic lung allograft dysfunction
$743,120Mark Eugene Snyder · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · HL
Improving Influenza Vaccination Delivery Across a Health System by the Electronic Health Records Patient Portal
$743,070Peter G Szilagyi · University Of California Los Angeles · R01 · FY2022 · AI
Production and Characterization of Human Immunoglobulin Producing Goats for Diagnostic Reagents and Therapeutics
$743,067Hua Wu · Sab Capra, Llc · R42 · FY2020 · AI
AGR2-superantigen vaccine conjugate for the treatment of pancreaticductal adenocarcinoma
$742,887Reeder McNeil Robinson · Leukogene Therapeutics, Inc. · R44 · FY2024 · CA
AGR2-superantigen vaccine conjugate for the treatment of pancreaticductal adenocarcinoma
$742,887Reeder McNeil Robinson · Leukogene Therapeutics, Inc. · R44 · FY2025 · CA
Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome in Allogeneic Hematopoietic Cell Transplant Recipients
$742,869Guang-Shing Cheng · Fred Hutchinson Cancer Center · R01 · FY2025 · HL
Natural Killer cells and the Immunogenetics of COVID-19
$742,765Paul John Norman · University Of Colorado Denver · R01 · FY2021 · AI
The Impact of SARS-CoV-2 Immune Dysregulation on Antifungal Immunity
$742,499Sixto Manuel Leal · University Of Alabama At Birmingham · R01 · FY2023 · AI
Conjugate vaccines for prevention and treatment of cryptococcosis
$742,433Arturo Casadevall · Johns Hopkins University · R01 · FY2021 · AI
Conjugate vaccines for prevention and treatment of cryptococcosis
$742,433Arturo Casadevall · Johns Hopkins University · R01 · FY2020 · AI